Fig. 7
From: Neural stem cells for disease modeling and evaluation of therapeutics for Tay-Sachs disease
Combination treatment of HPβCD and δ-tocopherol reduces lipid accumulation in TSD NSCs. a Nile Red staining images of TSD NSCs compared to WT NSCs following compound combination treatment. b Nile Red IxA of NSC HT134A and HT151A after 48 h incubation with HPβCD and δ-tocopherol. c Cell viability of TSD NSCs after compound combination treatment. * p < 0.5, *** p < 0.001 compared to untreated control. # p < 0.05, ### p < 0.001 compared to each other. IxA, integrated cell intensity